Brightwell Unveils A New Corporate Brand!

Brightwell Technologies has introduced a new corporate brand that will be rolled out immediately. This new brand recognizes and reinforces Brightwell's position as the leading supplier of imaging-based particle analysis instruments for the global biopharmaceutical market.

The primary elements of the new brand include a stronger emphasis on the company's biopharmaceutical market and core Micro-Flow Imaging or MFI technology, bold graphical elements in the company's logo and brands, and clear statements that define the company's business.

This new brand will be visible in Brightwell's web site, advertising and product marking. The company expects that its' customers will appreciate the new look of the brand – but more importantly the recognition that Brightwell and MFI are focused specifically on Advanced Particle Analysis for the Pharmaceutical Industry. Dave Thomas, Director of Sales and Marketing commented on this initiative "This new brand is simply recognition that Brightwell is committed to continuing to provide the best products, service and support to its customers. It also recognizes that MFI is now synonymous with imaging solutions for sub-visible particle analysis in this industry."

"We use the expression ‘Advanced Particle Analysis for the Pharmaceutical Industry' to clearly communicate our commitment to supporting our customers' efforts in a variety of pharmaceutical applications including discovery, formulation development, stability, process monitoring, and manufacturing QA/QC applications. Our achievements to date emerge from our technology leadership and partnerships with leading scientists in industry, academia and government. This marketing program strongly reinforces our commitment to continuing this leadership and partnerships in the future."

For more information, visit www.brightwelltech.com or www.mfitech.com.

SOURCE: Brightwell Technologies Inc.